You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graves´ ophthalmopathy

Showing 1 - 25 of 194
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Customized Multiple Orbital Wall Decompression for

Recruiting
  • Thyroid Eye Disease
  • Modified multiple orbital wall decompression
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Nov 17, 2022

Graves Ophthalmopathy Trial in Sofia (Orbital radiotherapy)

Completed
  • Graves Ophthalmopathy
  • Orbital radiotherapy
  • Sofia, Bulgaria
    University Hospital of Endocrinology
Mar 7, 2023

Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)

Completed
  • Graves Ophthalmopathy
  • Sofia, Bulgaria
    University Hospital of Endocrinology
Mar 29, 2023

Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)

Recruiting
  • Graves Ophthalmopathy
  • Hsinchu, Taiwan
  • +1 more
Dec 1, 2022

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Associated With Mental Fatigue in Graves' Disease

Recruiting
  • Graves Disease
  • +4 more
    • Gothenburg, Sweden
      Department of Endocrinology, Sahlgrenska University Hospital
    Jan 4, 2023

    Graves Ophthalmopathy Trial in Pisa (Sirolimus)

    Not yet recruiting
    • Graves Ophthalmopathy
    • Pisa, Italy
      Ospedale Cisanello-Endocrinology II
    Nov 2, 2022

    Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

    Recruiting
    • Thyroid Eye Disease
    • +11 more
    • Miami, Florida
    • +1 more
    Oct 31, 2023

    Glucocorticoids and Bone in Graves' Ophthalmopathy

    Active, not recruiting
    • Graves Ophthalmopathy
    • Aarhus C, Central Denmark Region, Denmark
    • +1 more
    Feb 21, 2022

    Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)

    Recruiting
    • Graves Ophthalmopathy
    • +2 more
    • Simvastatin 40mg
    • Malmö, Sweden
      Dpt. of Endocrinology, SUS Malmö
    Nov 17, 2021

    Sirolimus in Graves' Orbitopathy

    Completed
    • Graves Ophthalmopathy
    • Pisa, PI, Italy
      Endocrinologia II
    Apr 19, 2022

    Graves' Ophthalmopathy Trial in Canada (RVT-1401)

    Completed
    Has Results
    • Graves' Ophthalmopathy
    • Vancouver, British Columbia, Canada
    • +3 more
    Dec 24, 2021

    Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

    Recruiting
    • Graves Ophthalmopathy
    • Tocilizumab 20 Mg/mL Intravenous Solution
    • MethylPREDNISolone Injectable Solution
    • Milano, MI, Italy
    • +3 more
    Aug 3, 2022

    Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)

    Recruiting
    • Graves Ophthalmopathy
    • +8 more
    • Doxycycline hyclate
    • Placebo
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Nov 16, 2021

    Thyroid Eye Disease Trial (Satralizumab, Placebo)

    Not yet recruiting
    • Thyroid Eye Disease
    • (no location specified)
    Aug 4, 2023

    Active Moderate to Severe Graves' Orbitopathy Trial (SHR-1314)

    Not yet recruiting
    • Active Moderate to Severe Graves' Orbitopathy
    • (no location specified)
    May 23, 2022

    Thyroid Eye Disease Trial (Satralizumab, Placebo)

    Not yet recruiting
    • Thyroid Eye Disease
    • (no location specified)
    Oct 25, 2023

    Thyroid Eye Disease, TED Trial in Shanghai (IBI311)

    Recruiting
    • Thyroid Eye Disease, TED
    • Shanghai, Shanghai, China
      Ninth People's Hospital Affiliated to Shanghai Jiao Tong Univers
    Nov 9, 2023

    Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)

    Recruiting
    • Thyroid Eye Disease
    • TOUR006 - 20 MG
    • +2 more
    • Miami, Florida
      Site - 0103
    Oct 11, 2023

    Immunological Follow-up of Patients With Basedow's Orbitopathy

    Completed
    • Graves Orbitopathy
      • Montpellier, France
        Uhmontpellier
      Jan 10, 2022

      Thyroid Eye Disease Trial in Beijing (ZB001 for injection)

      Not yet recruiting
      • Thyroid Eye Disease
      • ZB001 for injection
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Mar 7, 2023

      Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via

      Terminated
      Has Results
      • Graves' Ophthalmopathy (GO)
      • RVT-1401 (Administered via subcutaneous injection)
      • Placebo (Administered via subcutaneous injection)
      • Beverly Hills, California
      • +24 more
      Aug 26, 2022

      Thyroid Eye Disease Trial in Shanghai (IBI311, )

      Recruiting
      • Thyroid Eye Disease
      • IBI311
      • placebo
      • Shanghai, Shanghai, China
        Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
      Mar 20, 2023

      Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

      Not yet recruiting
      • Thyroid Eye Disease
      • VRDN-001 10 mg/kg Drug:
      • (no location specified)
      Sep 7, 2023

      Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)

      Completed
      • Thyroid Associated Orbitopathy
      • Cairo, Egypt
        Cairo University
      Jul 15, 2022